Inspire Medical Systems (INSP) Net Income towards Common Stockholders (2017 - 2026)

Inspire Medical Systems has disclosed Net Income towards Common Stockholders across 10 years of filings, most recently posting -$11.3 million for Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at -$11.3 million, down 477.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $131.1 million (up 97.25% YoY), and the FY2025 annual result was $145.4 million, up 171.77% from the prior year.
• Net Income towards Common Stockholders came in at -$11.3 million for Q1 2026 at Inspire Medical Systems, down from $136.0 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $136.0 million in Q4 2025 to a low of -$16.8 million in Q3 2022.
• The 5-year median for Net Income towards Common Stockholders is -$3.6 million (2025), against an average of $7.2 million.
• Across the five-year window, Net Income towards Common Stockholders soared 368.67% in 2023 and sank 477.47% in 2026, its largest moves.
• Inspire Medical Systems' Net Income towards Common Stockholders stood at $3.2 million in 2022, then jumped by 368.67% to $14.8 million in 2023, then jumped by 138.6% to $35.2 million in 2024, then soared by 286.23% to $136.0 million in 2025, then plunged by 108.3% to -$11.3 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$11.3 million (Q1 2026), $136.0 million (Q4 2025), and $9.9 million (Q3 2025), per Business Quant data.